Engraftment of Gene-modified Umbilical Cord Blood Cells in Neonates with Adenosine Deaminase Deficiency

Overview

Journal Nat Med

Specialties General Medicine
Molecular Biology

Date 1995 Oct 1

PMID 7489356

Citations 96

Authors

D B Kohn

K I Weinberg

J A Nolta

L N Heiss

C Lenarsky

G M Crooks

M E Hanley

G Annett

J S Brooks

Affiliations

Soon will be listed here.

Abstract

Haematopoietic stem cells in umbilical cord blood are an attractive target for gene therapy of inborn errors of metabolism. Three neonates with severe combined immunodeficiency were treated by retroviral-mediated transduction of the CD34+ cells from their umbilical cord blood with a normal human adenosine deaminase complementary DNA followed by autologous transplantation. The continued presence and expression of the introduced gene in leukocytes from bone marrow and peripheral blood for 18 months demonstrates that umbilical cord blood cells may be genetically modified with retroviral vectors and engrafted in neonates for gene therapy.

Citing Articles

Advances in gene therapy for inborn errors of immunity.

Ott de Bruin L, Lankester A, Staal F Curr Opin Allergy Clin Immunol. 2023; 23(6):467-477.

PMID: 37846903 PMC: 10621649. DOI: 10.1097/ACI.0000000000000952.

Correcting inborn errors of immunity: From viral mediated gene addition to gene editing.

Castiello M, Ferrari S, Villa A Semin Immunol. 2023; 66:101731.

PMID: 36863140 PMC: 10109147. DOI: 10.1016/j.smim.2023.101731.

Therapeutics in paediatric genetic diseases: Current and future landscape.

Koh A, Jamuar S Singapore Med J. 2023; 64(1):7-16.

PMID: 36722512 PMC: 9979794. DOI: 10.4103/singaporemedj.SMJ-2021-376.

MPSI Manifestations and Treatment Outcome: Skeletal Focus.

De Ponti G, Donsante S, Frigeni M, Pievani A, Corsi A, Bernardo M Int J Mol Sci. 2022; 23(19).

PMID: 36232472 PMC: 9569890. DOI: 10.3390/ijms231911168.

Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID).

Secord E, Hartog N Ther Clin Risk Manag. 2022; 18:939-944.

PMID: 36172599 PMC: 9512634. DOI: 10.2147/TCRM.S350762.

References

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Williams D, Lemischka I, Nathan D, Mulligan R . Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature. 1984; 310(5977):476-80. DOI: 10.1038/310476a0. View

Triglia T, Peterson M, Kemp D . A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences. Nucleic Acids Res. 1988; 16(16):8186. PMC: 338531. DOI: 10.1093/nar/16.16.8186. View

Ochman H, Gerber A, Hartl D . Genetic applications of an inverse polymerase chain reaction. Genetics. 1988; 120(3):621-3. PMC: 1203539. DOI: 10.1093/genetics/120.3.621. View

Hock R, Miller A, Osborne W . Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood. 1989; 74(2):876-81. View

Jordan C, Lemischka I . Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 1990; 4(2):220-32. DOI: 10.1101/gad.4.2.220. View

Weinberg K, Parkman R . Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med. 1990; 322(24):1718-23. DOI: 10.1056/NEJM199006143222406. View

Kurtzberg J, Chaffee S, Santisteban I, Reisner E, Povey M, Hershfield M . Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency. J Clin Invest. 1990; 86(2):444-52. PMC: 296746. DOI: 10.1172/JCI114730. View

Nolta J, Kohn D . Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther. 1990; 1(3):257-68. DOI: 10.1089/hum.1990.1.3-257. View

10.

Wagner J, Broxmeyer H, Byrd R, Zehnbauer B, Schmeckpeper B, Shah N . Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood. 1992; 79(7):1874-81. View

11.

Broxmeyer H, Cooper S, Yoder M, Hangoc G . Human umbilical cord blood as a source of transplantable hematopoietic stem and progenitor cells. Curr Top Microbiol Immunol. 1992; 177:195-204. DOI: 10.1007/978-3-642-76912-2_15. View

12.

Nolta J, Yu X, Bahner I, Kohn D . Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J Clin Invest. 1992; 90(2):342-8. PMC: 443108. DOI: 10.1172/JCI115868. View

13.

van Beusechem V, Kukler A, Heidt P, Valerio D . Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci U S A. 1992; 89(16):7640-4. PMC: 49766. DOI: 10.1073/pnas.89.16.7640. View

14.

Wu D, Keating A . Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol. 1993; 21(2):251-6. View

15.

Hershfield M, Chaffee S, Sorensen R . Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy. Pediatr Res. 1993; 33(1 Suppl):S42-7; discussion S47-8. DOI: 10.1203/00006450-199305001-00236. View

16.

Blaese R . Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr Res. 1993; 33(1 Suppl):S49-53; discussion S53-5. DOI: 10.1203/00006450-199305001-00278. View

17.

Harrison D . Competitive repopulation in unirradiated normal recipients. Blood. 1993; 81(10):2473-4. View

18.

Stewart F, Crittenden R, Lowry P, Pearson-White S, Quesenberry P . Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood. 1993; 81(10):2566-71. View

19.

Bodine D, Moritz T, Donahue R, Luskey B, Kessler S, Martin D . Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. Blood. 1993; 82(7):1975-80. View

20.

Brenner M, Rill D, Holladay M, Heslop H, Moen R, Buschle M . Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet. 1993; 342(8880):1134-7. DOI: 10.1016/0140-6736(93)92122-a. View